ADAGIO THERAPEUTICS INC's ticker is and the CUSIP is 00534A102. A total of 61 filers reported holding ADAGIO THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3,190 | -95.6% | 2,900 | -82.2% | 0.00% | -100.0% |
| Q1 2024 | $72,465 | +232.8% | 16,321 | +195.3% | 0.00% | – |
| Q4 2023 | $21,776 | -12.4% | 5,527 | -62.2% | 0.00% | -100.0% |
| Q3 2023 | $24,860 | +46.4% | 14,623 | -9.6% | 0.00% | 0.0% |
| Q2 2023 | $16,986 | +106062.5% | 16,177 | +17.6% | 0.00% | 0.0% |
| Q1 2023 | $16 | -67.3% | 13,751 | -57.9% | 0.00% | -50.0% |
| Q4 2022 | $49 | -99.3% | 32,628 | +1238.3% | 0.00% | – |
| Q3 2022 | $7,000 | -50.0% | 2,438 | -42.3% | 0.00% | – |
| Q2 2022 | $14,000 | -68.2% | 4,227 | -56.0% | 0.00% | – |
| Q1 2022 | $44,000 | +18.9% | 9,613 | +86.9% | 0.00% | -100.0% |
| Q4 2021 | $37,000 | +23.3% | 5,144 | +631.7% | 0.00% | 0.0% |
| Q3 2021 | $30,000 | – | 703 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 6,398,250 | $29,176,000 | 26.83% |
| Foresite Capital Management V, LLC | 1,431,826 | $6,529,000 | 2.67% |
| Slate Path Capital LP | 3,735,000 | $17,032,000 | 0.87% |
| Bain Capital Life Sciences Investors, LLC | 1,937,207 | $8,834,000 | 0.86% |
| Alphabet Inc. | 5,680,785 | $25,904,000 | 0.84% |
| 683 Capital Management, LLC | 2,350,000 | $10,716,000 | 0.57% |
| Orbimed Advisors | 5,056,000 | $23,055,000 | 0.37% |
| Redmile Group, LLC | 1,920,960 | $8,760,000 | 0.27% |
| Artal Group S.A. | 1,000,000 | $4,560,000 | 0.19% |
| Triatomic Management LP | 25,800 | $118,000 | 0.10% |